\-\ Texto\\:\\ \ \(0\)\
\-\ vital\\ signs\\ stable\\,\\ afebrile\\,\\ hr\\ 66\\,\\ bp\\ 142\\/93\\,\\ respirations\\ non\\-labored\\ on\\ room\\ air\\;\\ abdomen\\ soft\\/tender\\ to\\ palpation\\ llq\\ near\\ prior\\ surgical\\ site\\ and\\ suprapubic\\ tenderness\\;\\ abdomen\\ is\\ non\\-distended\\ with\\ positive\\ bowel\\ sounds\\,\\ rectal\\ guaiac\\ negative\\ with\\ external\\ and\\ internal\\ hemorrhoids\\ and\\ slightly\\ enlarged\\ non\\-tender\\ prostate\\,\\ rectal\\ exam\\ causing\\ moderate\\ discomfort\\.\ \(0\)\
\-\ laboratory\\ values\\:\\ wbc\\ count\\ 6\\.7\\,\\ h\\&h\\ 14\\.2\\/40\\.7\\,\\ plts\\ 246\\,\\ electrolytes\\ wnl\\,\\ urinalysis\\ negative\\.\\ \\ protein\\/albumen\\ normal\\.\\ \\ liver\\ and\\ pancreatic\\ enzymes\\ normal\\.\ \(0\)\
\-\ mesenteric\\ panniculitis\\ is\\ a\\ rare\\ clinical\\ entity\\ which\\ currently\\ has\\ no\\ standardized\\ treatment\\.\\ patients\\ are\\ generally\\ treated\\ with\\ anti\\-inflammatory\\ or\\ immunosuppresive\\ agents\\ depending\\ on\\ severity\\ of\\ presentation\\.\\ because\\ our\\ patient\\ had\\ no\\ signs\\ of\\ obstruction\\ or\\ advanced\\ disease\\,\\ this\\ patient\\ was\\ treated\\ with\\ the\\ anti\\-inflammatory\\ agent\\ toradol\\ which\\ provided\\ relief\\ of\\ his\\ symptoms\\.\\ patient\\ was\\ continued\\ on\\ a\\ po\\ anti\\-inflammatory\\ regimen\\ for\\ home\\ use\\ and\\ followed\\ up\\ in\\ colorectal\\ clinic\\ to\\ assess\\ symptomatic\\ relief\\.\ \(0\)\
\-\ ct\\ abdomen\\ and\\ pelvis\\ w\\/\\ iv\\ and\\ po\\ contrast\\:\\ \\ \\ \ \(0\)\
\-\ abdomen\\:\\ subtle\\ focal\\ stranding\\ of\\ the\\ mesenteric\\ fat\\ \\(\\"misty\\ mesentery\\"\\)\\ is\\ noted\\ \\(best\\ seen\\ in\\ figure\\ 1\\)\\.\\ \\ a\\ suture\\ line\\ is\\ seen\\ in\\ the\\ area\\ of\\ sigmoid\\ colon\\,\\ likely\\ secondary\\ to\\ previous\\ colon\\ resection\\ and\\ colostomy\\ take\\ down\\.\\ the\\ remaining\\ large\\ bowel\\ demonstrates\\ no\\ gross\\ abnormalities\\ such\\ as\\ wall\\ thickening\\ or\\ surrounding\\ inflammatory\\ changes\\ to\\ suggest\\ an\\ acute\\ process\\.\\ no\\ free\\ intraperitoneal\\ air\\ or\\ obstruction\\.\\ no\\ free\\ fluid\\ is\\ seen\\.\\ \\ \ \(0\)\
\-\ pelvis\\:\\ \\ the\\ urinary\\ bladder\\ is\\ partially\\ distended\\.\\ \\ there\\ is\\ apparent\\ lateral\\ thickening\\ which\\ may\\ be\\ secondary\\ to\\ lack\\ of\\ distention\\.\\ the\\ prostate\\ is\\ within\\ upper\\ limits\\ of\\ normal\\ in\\ size\\.\\ seminal\\ vesicles\\ are\\ symmetric\\.\ \(0\)\
\-\ mesenteric\\ panniculitis\ \(2\)\
\-\ differential\\ diagnoses\\ for\\ \\"misty\\ mesentery\\"\\:\ \(0\)\
\-\ 1\\)\\ mesenteric\\ panniculitis\ \(0\)\
\-\ 2\\)\\ hypoalbuminemia\ \(0\)\
\-\ 3\\)\\ cirrhosis\ \(0\)\
\-\ 4\\)\\ lymphedema\\ of\\ the\\ mesentery\ \(0\)\
\-\ 5\\)\\ pancreatitis\\ \ \(0\)\
\-\ 6\\)\\ tuberculosis\ \(0\)\
\-\ 7\\)\\ hemorrhage\ \(0\)\
\-\ 8\\)\\ non\\-hodgkin\\â\\€\\™s\\ lymphoma\\ \ \(0\)\
\-\ differential\\ diagnosis\\ for\\ mesenteric\\ panniculitis\\:\ \(0\)\
\-\ 1\\)\\ lymphoma\ \(0\)\
\-\ 2\\)\\ lymphosarcoma\ \(0\)\
\-\ 3\\)\\ carcinoid\\ tumors\ \(0\)\
\-\ 4\\)\\ desmoid\\ tumors\ \(0\)\
\-\ 5\\)\\ infectious\\ diseases\\ \\(tuberculosis\\ and\\ histoplasmosis\\)\ \(0\)\
\-\ 6\\)\\ amyloidosis\ \(0\)\
\-\ 7\\)\\ peritoneal\\ mesothelioma\ \(0\)\
\-\ 8\\)\\ desmoplastic\\ carcinoma\\ metastases\ \(0\)\
\-\ 9\\)\\ whipple\\â\\€\\™s\\ disease\ \(0\)\
\-\ 10\\)\\ chronic\\ inflammation\\ due\\ to\\ foreign\\ body\ \(0\)\
\-\ 11\\)\\ reaction\\ to\\ adjacent\\ cancer\\ or\\ chronic\\ abscess\ \(0\)\
\-\ 12\\)\\ retroperitoneal\\ sarcoma\ \(0\)\
\-\ 44\\ y\\/o\\ hispanic\\ man\\ who\\ presents\\ with\\ a\\ complaint\\ of\\ 5\\ days\\ of\\ aching\\ llq\\ abdominal\\ pain\\ and\\ dysuria\\.\\ onset\\ was\\ gradual\\ after\\ he\\ experienced\\ a\\ bout\\ of\\ constipation\\ subsequently\\ followed\\ by\\ a\\ large\\ watery\\/liquidy\\ bowel\\ movement\\.\\ \ \(0\)\
\-\ his\\ past\\ medical\\ history\\ is\\ significant\\ for\\ diverticulosis\\,\\ sigmoid\\ diverticulitis\\ s\\/p\\ emergent\\ exploratory\\ laparotomy\\,\\ lysis\\ of\\ adhesions\\,\\ and\\ hartmann\\'s\\ procedure\\ 8\\ months\\ previously\\ and\\ reversal\\ colostomy\\ and\\ hartmann\\'s\\ take\\ down\\ 2\\ months\\ previously\\.\\ his\\ pmhx\\ also\\ includes\\ htn\\,\\ stable\\ angina\\ \\(last\\ episode\\ in\\ 2003\\)\\,\\ prostatitis\\.\\ his\\ past\\ surgical\\ history\\ also\\ includes\\ appendectomy\\.\\ his\\ family\\ history\\ is\\ negative\\ for\\ cancer\\ and\\ bowel\\ problems\\,\\ positive\\ for\\ htn\\ and\\ dm\\.\\ his\\ social\\ history\\ is\\ negative\\ for\\ tobacco\\ and\\ ivdu\\,\\ with\\ occasional\\ social\\ etoh\\.\ \(0\)\
\-\ mesenteric\\ panniculitis\\ is\\ rare\\ and\\ can\\ occur\\ independently\\ or\\ in\\ association\\ with\\ other\\ diseases\\.\\ our\\ patient\\ presented\\ similarly\\ to\\ some\\ of\\ the\\ 130\\ cases\\ previously\\ described\\ in\\ the\\ literature\\,\\ having\\ a\\ history\\ of\\ diverticulosis\\/itis\\ and\\ abdominal\\ surgery\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ panniculitis\\:\\ 0\\.058815139339993015\ \(0\)\
\-\ mesenteric\\:\\ 0\\.04048275103526041\ \(0\)\
\-\ misty\\:\\ 0\\.03019013158892636\ \(0\)\
\-\ \\)\\:\\ 0\\.02932346679917692\ \(0\)\
\-\ hartmann\\:\\ 0\\.027816339874679973\ \(0\)\
\-\ anti\\-inflammatory\\:\\ 0\\.027813293025536003\ \(0\)\
\-\ mesentery\\:\\ 0\\.026876709685841035\ \(0\)\
\-\ his\\:\\ 0\\.02530365439363286\ \(0\)\
\-\ colostomy\\:\\ 0\\.02168017730883047\ \(0\)\
\-\ llq\\:\\ 0\\.020106436454794718\ \(0\)\
\-\ previously\\:\\ 0\\.0184406083060957\ \(0\)\
\-\ bowel\\:\\ 0\\.018355846115649034\ \(0\)\
\-\ negative\\:\\ 0\\.0174802750779101\ \(0\)\
\-\ abdomen\\:\\ 0\\.01733824837599792\ \(0\)\
\-\ social\\:\\ 0\\.017078345984511654\ \(0\)\
\-\ take\\:\\ 0\\.01679279252924093\ \(0\)\
\-\ po\\:\\ 0\\.016724975312473193\ \(0\)\
\-\ rectal\\:\\ 0\\.016593241474021837\ \(0\)\
\-\ 8\\:\\ 0\\.016413275127993225\ \(0\)\
\-\ htn\\:\\ 0\\.016111796437647898\ \(0\)\
\-\ prostate\\:\\ 0\\.015544014742980969\ \(0\)\
\-\ h\\:\\ 0\\.015404213391884206\ \(0\)\
\-\ 142\\/93\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ hemorrhoids\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ 14\\.2\\/40\\.7\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ protein\\/albumen\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ toradol\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ lymphosarcoma\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ watery\\/liquidy\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ ivdu\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ diverticulosis\\/itis\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ relief\\:\\ 0\\.014935517560660925\ \(0\)\
\-\ sigmoid\\:\\ 0\\.014895925703122995\ \(0\)\
\-\ diseases\\:\\ 0\\.014741982594005646\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.01394036402603852\ \(0\)\
\-\ our\\:\\ 0\\.013910713126233334\ \(0\)\
\-\ soft\\/tender\\:\\ 0\\.013908169937339987\ \(0\)\
\-\ immunosuppresive\\:\\ 0\\.013908169937339987\ \(0\)\
\-\ prostatitis\\:\\ 0\\.013908169937339987\ \(0\)\
\-\ 246\\:\\ 0\\.013213880368661623\ \(0\)\
\-\ lymphedema\\:\\ 0\\.013213880368661623\ \(0\)\
\-\ 5\\:\\ 0\\.012843289841322757\ \(0\)\
\-\ non\\-labored\\:\\ 0\\.012721274080216793\ \(0\)\
\-\ hypoalbuminemia\\:\\ 0\\.012721274080216793\ \(0\)\
\-\ bout\\:\\ 0\\.012721274080216793\ \(0\)\
\-\ down\\:\\ 0\\.012561725846414537\ \(0\)\
\-\ stable\\:\\ 0\\.012062375339869882\ \(0\)\
\-\ free\\:\\ 0\\.012045209100748156\ \(0\)\
\-\ 6\\.7\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ standardized\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ includes\\:\\ 0\\.011797535602187792\ \(0\)\
\-\ seminal\\:\\ 0\\.011763027867998604\ \(0\)\
\-\ 130\\:\\ 0\\.011763027867998604\ \(0\)\
\-\ \\:\\:\\ 0\\.011612412493054777\ \(0\)\
\-\ is\\:\\ 0\\.011553920103795731\ \(0\)\
\-\ plts\\:\\ 0\\.011534378223093599\ \(0\)\
\-\ whipple\\:\\ 0\\.011534378223093599\ \(0\)\
\-\ aching\\:\\ 0\\.011534378223093599\ \(0\)\
\-\ colon\\:\\ 0\\.011492920924049107\ \(0\)\
\-\ rare\\:\\ 0\\.011364213009155123\ \(0\)\
\-\ vesicles\\:\\ 0\\.011332694942860065\ \(0\)\
\-\ independently\\:\\ 0\\.011332694942860065\ \(0\)\
\-\ 7\\:\\ 0\\.011213201639753671\ \(0\)\
\-\ tumors\\:\\ 0\\.010992179307090757\ \(0\)\
\-\ suprapubic\\:\\ 0\\.010840088654415235\ \(0\)\
\-\ desmoplastic\\:\\ 0\\.010840088654415235\ \(0\)\
\-\ angina\\:\\ 0\\.010840088654415235\ \(0\)\
\-\ lysis\\:\\ 0\\.010703029223467398\ \(0\)\
\-\ pelvis\\:\\ 0\\.010633874680108317\ \(0\)\
\-\ colorectal\\:\\ 0\\.01057613201087541\ \(0\)\
\-\ similarly\\:\\ 0\\.01057613201087541\ \(0\)\
\-\ 1\\:\\ 0\\.010445169698423152\ \(0\)\
\-\ guaiac\\:\\ 0\\.010347482365970405\ \(0\)\
\-\ obstruction\\:\\ 0\\.010319863180100806\ \(0\)\
\-\ signs\\:\\ 0\\.010299232650637173\ \(0\)\
\-\ or\\:\\ 0\\.010289617283873707\ \(0\)\
\-\ desmoid\\:\\ 0\\.010243673082038154\ \(0\)\
\-\ electrolytes\\:\\ 0\\.010145799085736873\ \(0\)\
\-\ history\\:\\ 0\\.010104576521464754\ \(0\)\
\-\ exploratory\\:\\ 0\\.010053218227397359\ \(0\)\
\-\ diverticulosis\\:\\ 0\\.009965387243857033\ \(0\)\
\-\ thickening\\:\\ 0\\.009919947156484081\ \(0\)\
\-\ air\\:\\ 0\\.009901584337506732\ \(0\)\
\-\ followed\\:\\ 0\\.009811218737598531\ \(0\)\
\-\ non\\-hodgkin\\:\\ 0\\.009726068849379021\ \(0\)\
\-\ cancer\\:\\ 0\\.009620428987550566\ \(0\)\
\-\ etoh\\:\\ 0\\.009583292121743659\ \(0\)\
\-\ enzymes\\:\\ 0\\.009516133366344205\ \(0\)\
\-\ dysuria\\:\\ 0\\.009516133366344205\ \(0\)\
\-\ positive\\:\\ 0\\.009496183528370263\ \(0\)\
\-\ 2\\:\\ 0\\.009452591591663765\ \(0\)\
\-\ respirations\\:\\ 0\\.00945150951705851\ \(0\)\
\-\ laparotomy\\:\\ 0\\.00945150951705851\ \(0\)\
\-\ reversal\\:\\ 0\\.00945150951705851\ \(0\)\
\-\ agent\\:\\ 0\\.009389236153752215\ \(0\)\
\-\ gradual\\:\\ 0\\.009389236153752215\ \(0\)\
\-\ suture\\:\\ 0\\.009329148277363053\ \(0\)\
\-\ past\\:\\ 0\\.009298628328583677\ \(0\)\
\-\ differential\\:\\ 0\\.009290958319701814\ \(0\)\
\-\ histoplasmosis\\:\\ 0\\.009271097675178667\ \(0\)\
\-\ hispanic\\:\\ 0\\.009271097675178667\ \(0\)\
\-\ dm\\:\\ 0\\.009271097675178667\ \(0\)\
\-\ \\,\\:\\ 0\\.009270892654701622\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.009160586508847211\ \(0\)\
\-\ regimen\\:\\ 0\\.009160586508847211\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.009160586508847211\ \(0\)\
\-\ mesothelioma\\:\\ 0\\.009160586508847211\ \(0\)\
\-\ urinalysis\\:\\ 0\\.009007141031638842\ \(0\)\
\-\ constipation\\:\\ 0\\.009007141031638842\ \(0\)\
\-\ emergent\\:\\ 0\\.009007141031638842\ \(0\)\
\-\ adhesions\\:\\ 0\\.009007141031638842\ \(0\)\
\-\ entity\\:\\ 0\\.008958903228613679\ \(0\)\
\-\ tobacco\\:\\ 0\\.008821843797665842\ \(0\)\
\-\ treated\\:\\ 0\\.00875976313727349\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.008746666916594027\ \(0\)\
\-\ 6\\:\\ 0\\.00874013753895505\ \(0\)\
\-\ for\\:\\ 0\\.00873931000085446\ \(0\)\
\-\ intraperitoneal\\:\\ 0\\.00869494658507385\ \(0\)\
\-\ carcinoid\\:\\ 0\\.00869494658507385\ \(0\)\
\-\ seen\\:\\ 0\\.008674456926717587\ \(0\)\
\-\ diagnoses\\:\\ 0\\.008654654637453657\ \(0\)\
\-\ pmhx\\:\\ 0\\.008654654637453657\ \(0\)\
\-\ appendectomy\\:\\ 0\\.008654654637453657\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.0086152890240552\ \(0\)\
\-\ agents\\:\\ 0\\.008576808106500305\ \(0\)\
\-\ s\\:\\ 0\\.008393039955871873\ \(0\)\
\-\ lymphoma\\:\\ 0\\.00836369395338865\ \(0\)\
\-\ chronic\\:\\ 0\\.008243115181188355\ \(0\)\
\-\ which\\:\\ 0\\.008194235893369256\ \(0\)\
\-\ secondary\\:\\ 0\\.008181609474345231\ \(0\)\
\-\ figure\\:\\ 0\\.008172032801595801\ \(0\)\
\-\ 4\\:\\ 0\\.008154013373900839\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.008028054861166792\ \(0\)\
\-\ months\\:\\ 0\\.007992949639349545\ \(0\)\
\-\ severity\\:\\ 0\\.007947142387107638\ \(0\)\
\-\ 66\\:\\ 0\\.007869881367791766\ \(0\)\
\-\ literature\\:\\ 0\\.007869881367791766\ \(0\)\
\-\ distention\\:\\ 0\\.007820245174515648\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.007795956415967778\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.007748388669209088\ \(0\)\
\-\ occasional\\:\\ 0\\.007725091319798507\ \(0\)\
\-\ depending\\:\\ 0\\.00761313454023883\ \(0\)\
\-\ remaining\\:\\ 0\\.00761313454023883\ \(0\)\
\-\ peritoneal\\:\\ 0\\.00761313454023883\ \(0\)\
\-\ w\\/\\:\\ 0\\.007591595529610644\ \(0\)\
\-\ experienced\\:\\ 0\\.007591595529610644\ \(0\)\
\-\ wnl\\:\\ 0\\.007508050727950657\ \(0\)\
\-\ 44\\:\\ 0\\.007508050727950657\ \(0\)\
\-\ diverticulitis\\:\\ 0\\.007508050727950657\ \(0\)\
\-\ advanced\\:\\ 0\\.007487786245678393\ \(0\)\
\-\ no\\:\\ 0\\.007366816358765427\ \(0\)\
\-\ 2003\\:\\ 0\\.007352277135132633\ \(0\)\
\-\ discomfort\\:\\ 0\\.0073337652924884275\ \(0\)\
\-\ assess\\:\\ 0\\.0073337652924884275\ \(0\)\
\-\ values\\:\\ 0\\.00731545144126112\ \(0\)\
\-\ movement\\:\\ 0\\.00731545144126112\ \(0\)\
\-\ abdominal\\:\\ 0\\.007314791911377107\ \(0\)\
\-\ episode\\:\\ 0\\.007244094084410832\ \(0\)\
\-\ foreign\\:\\ 0\\.007209500407497271\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.007192243279561017\ \(0\)\
\-\ pancreatic\\:\\ 0\\.007158886020097367\ \(0\)\
\-\ hr\\:\\ 0\\.007125955605837286\ \(0\)\
\-\ association\\:\\ 0\\.007109724879887725\ \(0\)\
\-\ stranding\\:\\ 0\\.0070777178028121205\ \(0\)\
\-\ distended\\:\\ 0\\.0070777178028121205\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.007053936650624119\ \(0\)\
\-\ vital\\:\\ 0\\.007000223639133831\ \(0\)\
\-\ gross\\:\\ 0\\.00697018201301926\ \(0\)\
\-\ home\\:\\ 0\\.006955356563116667\ \(0\)\
\-\ \\;\\:\\ 0\\.006936373933056827\ \(0\)\
\-\ normal\\:\\ 0\\.006881570828420039\ \(0\)\
\-\ 3\\:\\ 0\\.00685265591337856\ \(0\)\
\-\ urinary\\:\\ 0\\.0067734692116520985\ \(0\)\
\-\ problems\\:\\ 0\\.0067734692116520985\ \(0\)\
\-\ afebrile\\:\\ 0\\.0067602465299844445\ \(0\)\
\-\ complaint\\:\\ 0\\.0067602465299844445\ \(0\)\
\-\ subtle\\:\\ 0\\.0067211803009327815\ \(0\)\
\-\ having\\:\\ 0\\.0067211803009327815\ \(0\)\
\-\ partially\\:\\ 0\\.006695622680698747\ \(0\)\
\-\ 11\\:\\ 0\\.006695622680698747\ \(0\)\
\-\ symmetric\\:\\ 0\\.006682985510668572\ \(0\)\
\-\ lack\\:\\ 0\\.0066579875664542695\ \(0\)\
\-\ reaction\\:\\ 0\\.006645624128143504\ \(0\)\
\-\ subsequently\\:\\ 0\\.006633349317392455\ \(0\)\
\-\ generally\\:\\ 0\\.00658511151436729\ \(0\)\
\-\ clinic\\:\\ 0\\.006538195462675313\ \(0\)\
\-\ sarcoma\\:\\ 0\\.006515210838818908\ \(0\)\
\-\ apparent\\:\\ 0\\.006470146954713817\ \(0\)\
\-\ \\'s\\:\\ 0\\.006452214446462483\ \(0\)\
\-\ large\\:\\ 0\\.006399117917229725\ \(0\)\
\-\ count\\:\\ 0\\.006362417801613526\ \(0\)\
\-\ bp\\:\\ 0\\.00635200847614027\ \(0\)\
\-\ near\\:\\ 0\\.006331377759502985\ \(0\)\
\-\ causing\\:\\ 0\\.006321154870827464\ \(0\)\
\-\ provided\\:\\ 0\\.006310992652471617\ \(0\)\
\-\ continued\\:\\ 0\\.006300890388555198\ \(0\)\
\-\ room\\:\\ 0\\.0062908473757942425\ \(0\)\
\-\ infectious\\:\\ 0\\.0062908473757942425\ \(0\)\
\-\ metastases\\:\\ 0\\.006251254195279082\ \(0\)\
\-\ last\\:\\ 0\\.006251254195279082\ \(0\)\
\-\ suggest\\:\\ 0\\.0062317957044395016\ \(0\)\
\-\ described\\:\\ 0\\.0062317957044395016\ \(0\)\
\-\ external\\:\\ 0\\.006222148756291803\ \(0\)\
\-\ inflammation\\:\\ 0\\.006222148756291803\ \(0\)\
\-\ site\\:\\ 0\\.006184095439879627\ \(0\)\
\-\ best\\:\\ 0\\.006156100340561941\ \(0\)\
\-\ surgical\\:\\ 0\\.006151444418669361\ \(0\)\
\-\ s\\/p\\:\\ 0\\.00613768802587656\ \(0\)\
\-\ procedure\\:\\ 0\\.006128555584137926\ \(0\)\
\-\ 9\\:\\ 0\\.006048484067172105\ \(0\)\
\-\ limits\\:\\ 0\\.006031187669934941\ \(0\)\
\-\ line\\:\\ 0\\.006014064239567504\ \(0\)\
\-\ family\\:\\ 0\\.005997110350898477\ \(0\)\
\-\ 12\\:\\ 0\\.0059886959419902085\ \(0\)\
\-\ bladder\\:\\ 0\\.005939059748714091\ \(0\)\
\-\ slightly\\:\\ 0\\.0059147709901662205\ \(0\)\
\-\ patient\\:\\ 0\\.00586706801997526\ \(0\)\
\-\ to\\:\\ 0\\.005850248060862825\ \(0\)\
\-\ sounds\\:\\ 0\\.005836210021415033\ \(0\)\
\-\ symptomatic\\:\\ 0\\.005813327782010637\ \(0\)\
\-\ currently\\:\\ 0\\.005798241087349412\ \(0\)\
\-\ use\\:\\ 0\\.005783286155896066\ \(0\)\
\-\ also\\:\\ 0\\.005769245183801888\ \(0\)\
\-\ moderate\\:\\ 0\\.00575376251474109\ \(0\)\
\-\ previous\\:\\ 0\\.005682106504577561\ \(0\)\
\-\ process\\:\\ 0\\.005633673775401908\ \(0\)\
\-\ and\\:\\ 0\\.005548222779417692\ \(0\)\
\-\ occur\\:\\ 0\\.005489805871201264\ \(0\)\
\-\ laboratory\\:\\ 0\\.005392280369613127\ \(0\)\
\-\ abnormalities\\:\\ 0\\.005374596954962699\ \(0\)\
\-\ iv\\:\\ 0\\.00533976872852927\ \(0\)\
\-\ wbc\\:\\ 0\\.005334032278383239\ \(0\)\
\-\ \\&\\:\\ 0\\.0051393628290093\ \(0\)\
\-\ because\\:\\ 0\\.005119038213332274\ \(0\)\
\-\ was\\:\\ 0\\.00507676809356346\ \(0\)\
\-\ inflammatory\\:\\ 0\\.005074171137315109\ \(0\)\
\-\ in\\:\\ 0\\.005050994196886617\ \(0\)\
\-\ liver\\:\\ 0\\.005044899847316308\ \(0\)\
\-\ presentation\\:\\ 0\\.005040069579608017\ \(0\)\
\-\ enlarged\\:\\ 0\\.004992501832849326\ \(0\)\
\-\ \\(\\:\\ 0\\.004947683056464798\ \(0\)\
\-\ 10\\:\\ 0\\.004932575733470736\ \(0\)\
\-\ internal\\:\\ 0\\.0049056093687992654\ \(0\)\
\-\ size\\:\\ 0\\.0049056093687992654\ \(0\)\
\-\ palpation\\:\\ 0\\.004883457329363103\ \(0\)\
\-\ cases\\:\\ 0\\.004874676136953994\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.004870302370164444\ \(0\)\
\-\ surrounding\\:\\ 0\\.004810214493775283\ \(0\)\
\-\ disease\\:\\ 0\\.004783347743889397\ \(0\)\
\-\ a\\:\\ 0\\.0047537647478256995\ \(0\)\
\-\ body\\:\\ 0\\.004752163891590898\ \(0\)\
\-\ area\\:\\ 0\\.004626431924887444\ \(0\)\
\-\ adjacent\\:\\ 0\\.004626431924887444\ \(0\)\
\-\ abscess\\:\\ 0\\.004626431924887444\ \(0\)\
\-\ onset\\:\\ 0\\.004618871962200599\ \(0\)\
\-\ such\\:\\ 0\\.004574199982604199\ \(0\)\
\-\ resection\\:\\ 0\\.004563211738904484\ \(0\)\
\-\ clinical\\:\\ 0\\.004502242808332199\ \(0\)\
\-\ medical\\:\\ 0\\.004502242808332199\ \(0\)\
\-\ days\\:\\ 0\\.0044847162605684545\ \(0\)\
\-\ tenderness\\:\\ 0\\.004450192333701426\ \(0\)\
\-\ fat\\:\\ 0\\.004450192333701426\ \(0\)\
\-\ some\\:\\ 0\\.004443370297717053\ \(0\)\
\-\ wall\\:\\ 0\\.004238286164792373\ \(0\)\
\-\ changes\\:\\ 0\\.004193575301772364\ \(0\)\
\-\ focal\\:\\ 0\\.004178927404346579\ \(0\)\
\-\ fluid\\:\\ 0\\.004158628603773721\ \(0\)\
\-\ carcinoma\\:\\ 0\\.004147136421260045\ \(0\)\
\-\ likely\\:\\ 0\\.0041272088457802334\ \(0\)\
\-\ he\\:\\ 0\\.004082512571974348\ \(0\)\
\-\ y\\/o\\:\\ 0\\.004052446968869247\ \(0\)\
\-\ are\\:\\ 0\\.003989294084005485\ \(0\)\
\-\ presented\\:\\ 0\\.003988626087367139\ \(0\)\
\-\ up\\:\\ 0\\.003934669779202437\ \(0\)\
\-\ significant\\:\\ 0\\.003934669779202437\ \(0\)\
\-\ due\\:\\ 0\\.003904584166015136\ \(0\)\
\-\ who\\:\\ 0\\.003815014399215243\ \(0\)\
\-\ patients\\:\\ 0\\.003786942807133606\ \(0\)\
\-\ prior\\:\\ 0\\.0037570424181547317\ \(0\)\
\-\ on\\:\\ 0\\.003718618214205966\ \(0\)\
\-\ symptoms\\:\\ 0\\.003646673761811882\ \(0\)\
\-\ acute\\:\\ 0\\.003612807070387834\ \(0\)\
\-\ surgery\\:\\ 0\\.003553080589658005\ \(0\)\
\-\ upper\\:\\ 0\\.0035309597694669834\ \(0\)\
\-\ noted\\:\\ 0\\.0034681869665284136\ \(0\)\
\-\ man\\:\\ 0\\.0034604997313184916\ \(0\)\
\-\ other\\:\\ 0\\.003372668747778165\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0033599646075007186\ \(0\)\
\-\ can\\:\\ 0\\.00331887389121416\ \(0\)\
\-\ contrast\\:\\ 0\\.0032753008335751803\ \(0\)\
\-\ exam\\:\\ 0\\.0032144416779957843\ \(0\)\
\-\ may\\:\\ 0\\.0032094663850995267\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0031962691809129897\ \(0\)\
\-\ lateral\\:\\ 0\\.003162102817850257\ \(0\)\
\-\ had\\:\\ 0\\.0031572770877409386\ \(0\)\
\-\ after\\:\\ 0\\.0030273993195363055\ \(0\)\
\-\ presents\\:\\ 0\\.0029891169443628865\ \(0\)\
\-\ treatment\\:\\ 0\\.002961672876028916\ \(0\)\
\-\ of\\:\\ 0\\.0027928993341983527\ \(0\)\
\-\ within\\:\\ 0\\.0027913209047706875\ \(0\)\
\-\ has\\:\\ 0\\.002747773922079243\ \(0\)\
\-\ by\\:\\ 0\\.002436422779528895\ \(0\)\
\-\ be\\:\\ 0\\.0022564327454519333\ \(0\)\
\-\ as\\:\\ 0\\.0022133176470789857\ \(0\)\
\-\ there\\:\\ 0\\.0021775951309331997\ \(0\)\
\-\ the\\:\\ 0\\.0021305540450901233\ \(0\)\
\-\ ct\\:\\ 0\\.0020467528311507582\ \(0\)\
\-\ an\\:\\ 0\\.0020233987402135784\ \(0\)\
\-\ pain\\:\\ 0\\.0017870002868676962\ \(0\)\
\-\ this\\:\\ 0\\.0016457828995105016\ \(0\)\
\-\ \\.\\:\\ 0\\.0015804587988544573\ \(0\)\
\-\ with\\:\\ 0\\.0014024473161459384\ \(0\)\
